Feed REGMF
RE

RemeGen Co., Ltd.

REGMF · OTC

$9.96 -8.87% (-$0.97)
1M +4.40%
Market Cap ¥37.6B
P/E Ratio 6.50x
Div. Yield -
ROE 127.36%

Bulios Fair Price

$12.31

23.6% upside

Current Price

$9.96

Undervalued Fair Value Overvalued

According to Bulios Fair Price, REGMF is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
7/9
Valuation
86 /100
Cheap
P/E 6.50x
EV/EBITDA 7.23x
P/S 4.73x
Growth
78 /100
Growing
Rev. growth 60.38%
Book val. growth 10.17%
EPS growth N/A
Profitability
100 /100
Strong
Gross margin 92.68%
Net margin 72.71%
Op. margin 61.13%
Quality
95 /100
Excellent
ROIC 56.34%
ROE 127.36%
ROA 58.71%
Debt
100 /100
Low
Debt/Equity 0.04x
Current ratio 4.86x
Int. coverage 106.63x
Stability
34 /100
Moderate
Beta 0.45x
Rev. volatility 22.62%
EPS volatility 101.11%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about REGMF
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Jian Min Fang

Employees

3,048

Headquarters

Yantai

Upcoming events

04 NOV

Earnings

Upcoming earnings report

43d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.